MDMB-FUBINACA

Description

 RESTRICTED PRODUCT 

Schedule 9 (S9) Licence required.

This product requires an Australian government issued permit to hold or possess.

MDMB-FUBINACA, also known as MDMB(N)-Bz-F and FUB-MDMB, is a potent indazole-based synthetic cannabinoid receptor agonist sold as a designer drug. This Certified Spiking Solution® is suited for use in synthetic cannabinoid testing methods by LC/MS or GC/MS for applications in clinical toxicology, urine drug testing, and forensic analysis. For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.